Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy
Luke Maggs, Ananthan Sadagopan, Ali Sanjari Moghaddam, et al.
Trends in cancer (2021) Vol. 7, Iss. 12, pp. 1089-1101
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction
József Tı́már, Andrea Ladányi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5384-5384
Open Access | Times Cited: 83
Cancer immune escape: the role of antigen presentation machinery
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8131-8141
Open Access | Times Cited: 63
Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
Dimitrios C. Ziogas, Charalampos Theocharopoulos, Tilemachos Koutouratsas, et al.
Cancer Treatment Reviews (2022) Vol. 113, pp. 102499-102499
Closed Access | Times Cited: 58
β2-microglobulin functions as an endogenous NMDAR antagonist to impair synaptic function
Yue Gao, Yujuan Hong, Lihong Huang, et al.
Cell (2023) Vol. 186, Iss. 5, pp. 1026-1038.e20
Open Access | Times Cited: 40
The Immunology of DLBCL
Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 835-835
Open Access | Times Cited: 34
Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation
Pietro Crivello, Esteban Arrieta‐Bolaños, Meilun He, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 13, pp. 2416-2427
Open Access | Times Cited: 25
Targeting MHC-I inhibitory pathways for cancer immunotherapy
Jun Wang, Lu Qiao, Xufeng Chen, et al.
Trends in Immunology (2024) Vol. 45, Iss. 3, pp. 177-187
Closed Access | Times Cited: 12
Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer
Hanming Yao, Chengzhi Huang, Jinmao Zou, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 8
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 19
Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I
Valentina Ferrari, Antonino Lo Cascio, Alessia Melacarne, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1717-1730.e4
Open Access | Times Cited: 18
Unravelling immune microenvironment features underlying tumor progression in the single-cell era
Qilian Du, Qi An, Jiajun Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Multiple Immunomodulatory Strategies Based on Targeted Regulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Immune Homeostasis against Hepatocellular Carcinoma
Shiji Fang, Liyun Zheng, Gaofeng Shu, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 8811-8826
Closed Access | Times Cited: 6
Monocyte/Macrophage‐Mediated Transport of Dual‐Drug ZIF Nanoplatforms Synergized with Programmed Cell Death Protein‐1 Inhibitor Against Microsatellite‐Stable Colorectal Cancer
Xietao Ye, Yuping Liu, Liangyin Wei, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse events
Ning Jiang, Yue Yu, Dawei Wu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 2, pp. 737-747
Closed Access | Times Cited: 16
Identification of a gene score related to antigen processing and presentation machinery for predicting prognosis in head and neck squamous cell carcinoma and its potential implications for immunotherapy
Xueliang Fang, Qingjie Li, Li Wang, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 5
Chaperones and Catalysts: How Antigen Presentation Pathways Cope With Biological Necessity
David H. Margulies, Daniel K. Taylor, Jiansheng Jiang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
Silvia D’Amico, Patrizia Tempora, Ombretta Melaiu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 4
AI Model for Predicting Anti-PD1 Response in Melanoma Using Multi-Omics Biomarkers
Axel Gschwind, Stephan Ossowski
Cancers (2025) Vol. 17, Iss. 5, pp. 714-714
Open Access
B7H3 in Gastrointestinal Tumors: Role in Immune Modulation and Cancer Progression: A Review of the Literature
Sylwia Mielcarska, Anna Kot, Agnieszka Kula, et al.
Cells (2025) Vol. 14, Iss. 7, pp. 530-530
Open Access
Clinical Applications of the Molecular Landscape of Melanoma: Integration of Research into Diagnostic and Therapeutic Strategies
Imre Szabó, Gabriella Emri, Andrea Ladányi, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1422-1422
Open Access
Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer
Hao Luo, Jinlu Shan, Hong Zhang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 960-970
Open Access | Times Cited: 17
Transcriptome-based identification of tumor-reactive and bystander CD8 + T cell receptor clonotypes in human pancreatic cancer
Zibo Meng, Aaron Rodriguez Ehrenfried, Chin Leng Tan, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 722
Closed Access | Times Cited: 9
Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma
Giulia Cattaneo, Marco Ventin, Shahrzad Arya, et al.
Cancer Letters (2024) Vol. 587, pp. 216713-216713
Open Access | Times Cited: 3
Mechanistic rationales for combining immunotherapy with radiotherapy
Alexander Chi, Nam P. Nguyen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top